We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approval of EMFLAZA for Treatment of Duchenne's Muscular Dystrophy

News   Feb 21, 2017 | Original Story From Marathon Pharmaceuticals, LLC.

 
FDA Approval of EMFLAZA for Treatment of Duchenne's Muscular Dystrophy
 
 
 

RELATED ARTICLES

The Next Generation of Hearing Implants Could Be Soft

News

Close to half a million people around the world suffer from a serious hearing impairment. Cochlear implants, whilst useful for some patients, do not help people whose inner ear is damaged or whose auditory nerve does not function properly. Now, researchers have developed a soft variant of an implant that communicates directly with the brainstem.

READ MORE

Microbleeds May Be Sign of Trauma After Minor Brain Injury

News

Using advanced imaging, researchers have uncovered new information regarding traumatic microbleeds, which appear as small, dark lesions on MRI scans after head injury but are typically too small to be detected on CT scans. The findings published in Brain suggest that traumatic microbleeds are a form of injury to brain blood vessels and may predict worse outcomes.

READ MORE

AI Could Warn About Drug Interaction Side Effects

News

Researchers have designed an algorithm that analyzes data on drug-drug interactions listed in reports — compiled by the Food and Drug Administration and other organizations — for use in a possible alert system that would let patients know when a drug combination could prompt dangerous side effects.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE